Haleon Plc Correlations
HLN Stock | USD 9.53 0.01 0.10% |
The current 90-days correlation between Haleon plc and Teva Pharma Industries is 0.35 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Haleon Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Haleon plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Haleon Plc Correlation With Market
Modest diversification
The correlation between Haleon plc and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Haleon plc and DJI in the same portfolio, assuming nothing else is changed.
Haleon |
Moving together with Haleon Stock
0.63 | INZY | Inozyme Pharma | PairCorr |
0.65 | PLRX | Pliant Therapeutics | PairCorr |
0.62 | TERN | Terns Pharmaceuticals Downward Rally | PairCorr |
Moving against Haleon Stock
0.57 | INKT | Mink Therapeutics Upward Rally | PairCorr |
0.33 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
0.5 | BPMC | Blueprint Medicines Corp | PairCorr |
0.55 | FNMFO | Federal National Mortgage | PairCorr |
0.38 | AVAL | Grupo Aval | PairCorr |
0.31 | TGNA | Tegna Inc | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Haleon Stock performing well and Haleon Plc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Haleon Plc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TEVA | 2.01 | 0.15 | 0.00 | (0.08) | 3.15 | 3.66 | 29.83 | |||
BHC | 2.00 | (0.11) | 0.00 | (0.25) | 0.00 | 4.27 | 21.50 | |||
ZTS | 1.12 | (0.17) | 0.00 | (0.49) | 0.00 | 1.77 | 5.49 | |||
TAK | 0.79 | (0.08) | 0.00 | (0.29) | 0.00 | 1.39 | 4.86 | |||
RDY | 1.22 | (0.22) | 0.00 | (6.29) | 0.00 | 1.96 | 10.27 | |||
EBS | 3.75 | 0.42 | 0.07 | 1.11 | 4.74 | 8.29 | 36.29 | |||
HCM | 2.22 | (0.67) | 0.00 | (1.80) | 0.00 | 5.47 | 15.25 | |||
VTRS | 1.32 | (0.02) | (0.05) | (0.02) | 1.48 | 1.96 | 16.44 | |||
PETQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NBIX | 1.19 | 0.43 | 0.23 | (2.61) | 1.11 | 3.10 | 11.43 |
Haleon Plc Corporate Management
Tamara Rogers | Chief Officer | Profile | |
Adrian Morris | General Counsel | Profile | |
Brian McNamara | CEO Director | Profile | |
Bjarne Tellmann | General Counsel | Profile | |
Claire Dickson | Chief Officer | Profile |